News Items
http://www.fda.gov/bbs/topics/ANSWERS/ANS01051.html
"FDA, today, is taking steps to remove phenylpropanolamine from all drug products
and has requested that all drug companies discontinue marketing products containing
phenylpropanolamine. The FDA today issued a public health advisory concerning
the risk of hemorrhagic stroke, or bleeding into the brain, associated with phenylpropanolamine
hydrochloride."
http://63.75.126.224/Google/fda_search.pl?client=fdagov&site=fdagov&restrict=
medwatch&searchselector=&q=ppa
MedWatch
- 2001 Safety Information
... The product contains norephedrine (also known as phenylpropanolamine
or PPA), caffeine, yohimbine, diiodothyronine, and sodium usniate. FDA is also
advising ...
Important
Safety Information - 2000
... 2000) Norplant (levonorgestrel implants) (Updated: 9/13/2000) Phenylpropanolamine
hydrochloride (PPA) (Posted: 11/6 /2000) Propulsid (cisapride) (Updated: 4/13
...
MedWatch
- Lipokinetix Dear Doc Letter
... metabolic rate'. The product contains norephedrine (also known as phenylpropanolamine
or PPA), caffeine, yohimbine, diiodothyronine, and sodium usniate. ...
http://www.fda.gov/medwatch/safety/2001/lipokinetix_deardoc.pdf
... rate'.
The product contains norephedrine (also known as phenylpropanolamine or PPA),
caffeine, yohimbine, diiodothyronine, and sodium usniate. FDA has issued a ...
|
